REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Drofunvivir S.A.S. (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Drofunvivir S.A.S. Profile Updated: May 05, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Drofunvivir S.A.S. is based in Colombia. The head office is in Cali. It operates in the Pharmacies and Drug Stores industry. Drofunvivir S.A.S. was incorporated on April 26, 2023. It currently has a total number of 16 (2025) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 345.09% in 2024. During that time, Drofunvivir S.A.S.’s total assets grew by 95.27%. The net profit margin of Drofunvivir S.A.S. decreased by 1.34% in 2024.

Headquarters
Cr 1 G 64 A 38
Cali; Valle del Cauca;

Contact Details: Purchase the Drofunvivir S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Drofunvivir S.A.S. report to view the information.
Financial Auditors:
Purchase the Drofunvivir S.A.S. report to view the information.
Incorporation Date:
April 26, 2023
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
25%
Purchase this report to view the information.
25%
Company Performance
Financial values in the chart are available after Drofunvivir S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
345.09%▲
Total operating revenue
345.09%▲
Operating profit (EBIT)
20.95%▲
Net Profit (Loss) for the Period
21.97%▲
Total Assets
95.27%▲
Total Equity
65.54%▲
Operating Profit Margin (ROS)
-1.4%▼
Net Profit Margin
-1.34%▼
Return on Equity (ROE)
-0.6%▼
Quick Ratio
-3.91%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo